KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) are accompanied by inactivation of the von Hippel–Lindau gene (VHL). It is known that VHL is a
target for several
successful amplification of specific DNA
targets. The inhibitory effect of pAsp is due to its polymeric
Sun, Pengfei,
Wang, Jiaqi,
Ilyasova, Tatiana,
Shumadalova, Alina,
Agaverdiev, Murad,
Wang, Chunlei (2023) binding to complementary
target sequences within messenger RNA (mRNA) molecules, consequently exerting a
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) in
target cells (hepatocytes, adipocytes, skeletal muscle cells), resulting in the termination
associated with complex application of
therapeutic measures. Effectiveness of the program was proven
Gilyazova, Irina,
Gimalova, Galiya,
Nizamova, Aigul,
Nizamova, Aigul,
Ishbulatova, Ekaterina,
Pavlov, Valentin,
Khusnutdinova, Elza (2024) , regulatory mechanisms, and
therapeutic potential of ncRNAs including microRNA (miRNA), long ncRNA (lnc